Skip to main content

Resultados relacionados

Resultados totales (Incluyendo duplicados): 3
Encontrada(s) 1 página(s)

Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Outcomes of patients with heart failure with preserved ejection fraction discharged on treatment with neurohormonal antagonists after an episode of decompensation

  • Tost, Josep|||0000-0003-3846-9616
  • Llorens Soriano, Pere|||0000-0002-9291-7179
  • Cotter, Gad|||0000-0002-9613-3339
  • Davison, Beth A.
  • Jacob, Javier|||0000-0003-1101-1066
  • Gil, Víctor
  • Herrero-Puente, Pablo|||0000-0002-5529-5008
  • Martín-Sánchez, Francisco Javier|||0000-0002-5970-725X
  • Donea, Ruxandra
  • Rodríguez, Beatriz|||0000-0002-0402-3838
  • Lucas-Imbernon, Francisco Javier
  • Andueza, Juan Antonio
  • Mecina, Ana Belén
  • Torres Gárate, Raquel|||0000-0002-8731-9350
  • Piñera, Pascual|||0000-0001-9213-9357
  • Alquézar-Arbé, A.|||0000-0003-4164-274X
  • Espinosa, Bego|||0000-0001-9531-6451
  • Mebazaa, A.
  • Chioncel, O.|||0000-0002-3197-3628
  • Miró, Oscar|||0000-0002-7924-9751
Aims: To analyze the frequency with which patients with heart failure with preserved ejection fraction (HFpEF) discharged after an acute heart failure (AHF) episode are treated with antineurohormonal drugs (ANHD), the variables related to ANHD prescription and their relationship with outcomes. Methods: We included consecutive HFpEF patients (left ventricular ejection fraction ≥50%) discharged after an AHF episode from 45 Spanish hospitals whose chronic medications and treatment at discharge were available. Patients were classified according to whether they were discharged with or without ANHD, including beta-blockers (BB), renin-angiotensin-aldosterone-system inhibitors (RAASi) and mineralcorticosteroid-receptor antagonists (MRA). Co-primary outcomes consisted of 1-year all-cause mortality and 90-day combined adverse event (revisit to emergency department -ED-, hospitalization due to AHF or all-cause death). Secondary outcomes were 90-day adverse events taken individually. Adjusted associations of ANHD treatment with outcomes were calculated. Results: We analyzed 3,305 patients with HFpEF (median age: 83, 60% women), 2,312 (70%) discharged with ANHD. The ANHD most frequently prescribed was BB (45.8%). The 1-year mortality was 26.9% (adjusted HR for ANHD patients:1.17, 95%CI=0.98-1.38) and the 90-day combined adverse event was 54.4% (HR=1.14, 95%CI=0.99-1.31). ED revisit was significantly increased by ANHD (HR=1.15, 95%CI=1.01-1.32). MRA and BB were associated with worse results in some co-primary or secondary endpoints, while RAASi (alone) reduced 90-day hospitalization (HR=0.73, 98%CI=0.56-0.96). Conclusion: 70% of HFpEF patients are discharged with ANHD after an AHF episode. ANHD do not seem to reduce mortality or adverse events in HFpEF patients, only RAASi could provide some benefits, reducing the risk of hospitalization for AHF.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Early intravenous nitroglycerin use in prehospital setting and in the emergency department to treat patients with acute heart failure, Insights from the EAHFE Spanish registry

  • Miró, Oscar|||0000-0002-7924-9751
  • Llorens Soriano, Pere|||0000-0002-9291-7179
  • Freund, Yonathan
  • Davison, Beth A.
  • Takagi, Koji
  • Herrero-Puente, Pablo|||0000-0002-5529-5008
  • Jacob, Javier|||0000-0003-1101-1066
  • Martín-Sánchez, Francisco Javier|||0000-0002-5970-725X
  • Gil, Víctor
  • Rossello, Xavier|||0000-0001-6783-8463
  • Alquézar-Arbé, A.|||0000-0003-4164-274X
  • Jiménez-Fábrega, Francesc X.
  • Masip, Josep|||0000-0002-8612-9889
  • Mebazaa, Alexandre|||0000-0001-8715-7753
  • Cotter, Gad|||0000-0002-9613-3339
Background and objective: Although recommended for the treatment of acute heart failure (AHF), the use of intravenous (IV) nitroglycerin (NTG) is supported by scarce and contradicting evidence. In the current analysis, we have assessed the impact of IV NTG administration by EMS or in emergency department (ED) on outcomes of AHF patients. Methods: We analyze AHF patients included by 45 hospitals that were delivered to ED by EMS. Patients were grouped according to whether treatment with IV NTG was started by EMS before ED admission (preED-NTG), during the ED stay (ED-NTG) or were untreated with IV NTG (no-NTG, control group). In-hospital, 30-day and 365-day all-cause mortality, prolonged hospitalization (.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Pronóstico de la insuficiencia cardíaca aguda basado en datos clínicos de congestión, Prognosis of acute heart failure based on clinical data of congestion

  • Espinosa, Bego|||0000-0001-9531-6451
  • Llorens Soriano, Pere|||0000-0002-9291-7179
  • Gil, V.
  • Rossello, X.
  • Jacob, Javier|||0000-0003-1101-1066
  • Herrero-Puente, Pablo|||0000-0002-5529-5008
  • Martín-Sánchez, Francisco Javier|||0000-0002-5970-725X
  • Alquézar-Arbé, A.|||0000-0003-4164-274X
  • Masip, J.
  • Miró, None
Antecedentes y objetivos: Evaluar si los síntomas/signos de congestión en pacientes con insuficiencia cardíaca aguda (ICA) atendidos en los servicios de urgencias hospitalarios (SUH) permiten predecir la evolución a corto plazo. Pacientes y métodos: Pacientes consecutivos diagnosticados de ICA en 45 SUH del registro EAHFE. Recogimos variables clínicas de congestión sistémica (edemas en miembros inferiores, ingurgitación yugular, hepatomegalia) y pulmonar (disnea de esfuerzo, disnea paroxística nocturna, ortopnea y crepitantes pulmonares) analizando su asociación con la mortalidad por cualquier causa a 30 días, de forma cruda y ajustada por diferencias entre grupos. Resultados: Analizamos 18.120 pacientes (mediana = 83 años, rango intercuartil [RIC] = 76-88; mujeres = 55,7%). El 44,6% presentaba., Background and objectives: This work aims to assess whether symptoms/signs of congestion in patients with acute heart failure (AHF) evaluated in hospital emergency departments (HED) allows for predicting short-term progress. Patients and methods: The study group comprised consecutive patients diagnosed with AHF in 45 HED from EAHFE Registry. We collected clinical variables of systemic congestion (edema in the lower extremities, jugular vein distention, hepatomegaly) and pulmonary congestion (dyspnea on exertion, paroxysmal nocturnal dyspnea, orthopnea, and pulmonary crackles) and analyzed their individual and group association with all-cause 30-day of mortality crudely and adjusted for differences between groups. Results: We analyzed 18,120 patients (median=83 years, interquartile range [IQR]=76-88; women=55.7%). Of them, 44.6% had.